患有心力衰竭和功能下降的患者的治疗缺口:一个前性队列研究
Chen Hsiang Ma1, Arthur Qi1, Luke Gagnon1
1Division of Cardiology, Department of Medicine, Mazankowski Alberta Heart Institute, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
ESC heart failure
|November 17, 2025
概括
在患有功能障碍的患者中,心力衰竭 (HF) 治疗的使用率低于最佳,导致结果更差. 实施针对高频率治疗的有针对性的策略对于这种高风险人群至关重要.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 优化心力衰竭 (HF) 药物治疗至关重要,特别是在患有功能障碍的患者中.
- 目前关于不同功能水平的HF治疗模式的数据有限.
研究的目的:
- 评估不同水平的功能和左心室喷射率 (LVEF) 的患者中高功能疗法的纵向治疗模式.
- 确定高频疗法利用和遵守指导方针导向医疗疗 (GDMT) 的差异.
主要方法:
- 在2年内对1401名HF患者进行前性观察队列研究.
- 根据估计的膜过率 (eGFR) 和LVEF分层的HF治疗使用和剂量强度.
- 分析临床结果,高胆固醇血发病率,以及使用不充分的高胆固醇治疗的原因.
主要成果:
- 在EGFR<30毫升/分钟/1.73米2.2的患者中观察到较低的氨酸- ангиотензин系统抑制剂 (RASi) 和矿物质皮质醇受体对抗剂 (MRA) 的利用率.
- 较少的患者在中度至严重的功能障碍中达到RASi和MRA的指导剂量.
- 患有eGFR<60mL/min/1.73m2的患者有较高的全因死亡率,住院率和高血症.
- 功能障碍是RASi在EGFR<30mL/min/1.73m2的患者中使用不足的主要原因.
结论:
- 在对伴随性功能障碍患者的基于证据的HF治疗方法的利用方面,仍然存在显著的差距.
- 需要有针对性的战略来改善这种脆弱人群中HF治疗的实施和坚持.
- 解决治疗使用障碍可以改善HF和功能障碍患者的临床结果.
相关概念视频
01:22Heart Failure VI: Adjunct Therapies
243
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
243
01:22Heart Failure Drugs: Diuretics
779
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
779
01:30Heart Failure V: Medical Management
207
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
207
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
902
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
902
01:11Renal Failure: Dose Adjustments
416
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
416
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
226
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
226